More on Neogenix Laboratoire
NeoGenix Laboratoire Sdn Bhd (1191967-W) is a medical diagnostic and research laboratory specializing in molecular infectious diseases and oncology testing. It was founded in June 2016 by an experienced team of knowledge-based professionals that continues to manage its operations.
NeoGenix Laboratoire leads the revolution in precision health, defining and developing the next generation of care. It aspires to be a premier diagnostic laboratory service provider in every community and region that it serves.
Its Diagnostic Department comprises a Molecular Infectious Disease Laboratory and a Molecular Genetic and Oncology Laboratory that offer the highest quality molecular diagnostic tests for medical practitioners, patients and health care providers. These utilise the techniques of standard PCR (polymerase chain reaction test), real-time PCR, microarray analysis, mass spectrometry and next-generation sequencing (NGS).
The services offered by NeoGenix incorporate strict quality controls in compliance with international standards and guidelines of Good Laboratory Practice (GLP) and ISO 15189. To indicate the accuracy and precision attained in its diagnostic testing, NeoGenix also participates in international external quality assurance programmes. Bby the College of American Pathologists (CAP), Genomics Quality Assessment (GenQA), Royal College of Pathologists of Australasia (RCPA) and Quality Control for Molecular Diagnostics (QCMD).
NeoGenix has an extensive network of suppliers which enables it to closely collaborate with clients on customised or evolving diagnostic and research projects. The Research Department, with its dedicated R&D lab, collaborates widely across academia and industry. It offers a wide range of customised life science services such as DNA and RNA extraction, Bioanalyzer applications, tapestation and gene expression microarray services, NGS and bioinformatics analysis.
NeoGenix was the first private laboratory in Malaysia offering the Covid-19 RT-PCR test to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It also works with the Malaysian Ministry of Health and Ministry of Foreign Affairs, and with the Johor State Department of Health and Immigration Department of Malaysia on standard operating procedures to facilitate essential travel between Malaysia and Singapore via the Reciprocal Green Lane and Periodic Commuting Arrangement.
Neogenix Laboratoire performs laboratory testing for all patients and does not discriminate based on race, nationality, sex, age, disability or gender identity.
 These utilise the techniques of standard PCR (polymerase chain reaction test), real-time PCR, microarray analysis, mass spectrometry and next-generation sequencing (NGS).
 By the College of American Pathologists (CAP), Genomics Quality Assessment (GenQA), Royal College of Pathologists of Australasia (RCPA) and Quality Control for Molecular Diagnostics (QCMD).